ArticleChina CDC weekly2024
Coal Worker's Pneumoconiosis-Targeted Lipidomics Reveals Aberrant Phospholipid Metabolism for Early-Stage Diagnosis.
Article in China CDC weekly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pneumoconiosis is the most prevalent occupational disease in China, with coal worker pneumoconiosis (CWP) demonstrating the highest incidence. Studies have indicated that phospholipids may be associated with CWP. Methods: In this study, serum was obtained from 62 patients with pneumoconiosis, 105 coal dust-exposed workers, and 50 healthy individuals and analyzed via targeted lipidomics using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). After initially identifying phospholipids with significant differences through univariate and multivariate statistical analyses, receiver operating characteristic (ROC) analysis was performed. The differential phospholipids identified in patient samples were then integrated to assess their diagnostic potential for CWP using a support vector machine (SVM). Results: Compared with healthy subjects, the levels of Lyso-PS (18:0) were decreased, while PC (16:0), PC (18:0), PC (16:0/18:1), PI (16:0/18:1), PS (18:1), PG (16:0), and PG (18:0/18:1) were significantly increased in the pneumoconiosis group, with an area under the curve (AUC)>0.7. Moreover, compared with the dust-exposed group, Lyso-PC (16:0), PC (16:0), PC (16:0/18:1), PI (16:0/18:1), and PG (16:0) were significantly elevated in the pneumoconiosis group, with an AUC>0.7. The diagnostic model, including PC (16:0), PC (16:0/18:1), PI (16:0/18:1), and PG (16:0), demonstrated excellent performance with an AUC of 0.956. Discussion: The serum phospholipid profiles of patients with pneumoconiosis differed significantly from those of controls, including differences in PC, Lyso-PC, PI, PS, Lyso-PS, and PG. Among these, a diagnostic model incorporating PC (16:0), PC (16:0/18:1), PI (16:0/18:1), and PG (16:0) demonstrated superior screening efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.